prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Normal, Clinical Diagnosis & History: 1/0 female with left breast IDC. Specimens Submitted: 1: SP: Level three left axillary lymph nodes. 2: SP: Level two left axillary lvmph nodes. 3: SP: Lateral left breast skin. 4: SP: Right upper abdominal skin tag. 5: SP: Left breast and level 1 axillary lymph nodes. DIAGNOSIS: 1). SOFT TISSUE, LEVEL III LEFT AXILLA; EXCISION: - BENIGN FIBROADIPOSE TISSUE. - NO LYMPH NODE IDENTIFIED. 2). LYMPH NODES, LEVEL II LEFT AXILLA; EXCISION: - THREE BENIGN LYMPH NODES (0/3). 3). SOFT TISSUE, LATERAL LEFT BREAST; EXCISION: - ONE BENIGN LYMPH NODE (0/1). - BENIGN FIBROADIPOSE TISSUE. 4). SKIN, RIGHT UPPER ABDOMINAL TAG; EXCISION: - IRRITATED SEBORRHEIC KERATOSIS. 5). BREAST AND LEVEL I AXILLARY LYMPH NODES, LEFT; MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, HISTOLOGIC GRADK III/III (SLIGHT OR NO. TUBULE FORMATION). NUCLEAR GRADE II/III (MODERATE VARIATION IN SIZE AND. SHAPE) WITH AREAS OF LOBULAR GROWTH, MEASURING 11.0 CM IN LARGEST DIMENSION. GROSSLY. - DUCTAL CARCINOMA IN SITU (DCIS) IS ALSO IDENTIFIED, SOLID TYPE, WITH. MODERATE HIGH NUCLEAR GRADE AND EXTENSIVE NECROSIS. - LOBULAR INVOLVEMENT BY DCIS IS PRESENT. THE DCIS CONSTITUTES <= 25% OF THE TOTAL TUMOR MASS, AND IS PRESENT. ADMIXED WITH AND AWAY FROM THE INVASIVE COMPONENT. - THE INVASIVE CARCINOMA IS LOCATED IN THE UPPER OUTER QUADRANT, UPPER INNER. QUADRANT AND LOWER OUTER QUADRANT. - THE DCIS IS LOCATED IN THE UPPER OUTER QUADRANT, UPPER INNER QUADRANT AND. LOWER OUTER QUADRANT. - NO INVOLVEMENT OF THE NIPPLE BY EITHER IN SITU OR INVASIVE CARCINOMA IS. IDENTIFIED. CALCIFICATIONS ARE PRESENT IN THE IN SITU AND INVASIVE CARCINOMA, AND IN. BENIGN BREAST PARENCHYMA. EXTENSIVE VASCULAR INVASION IS PRESENT. NO INVOLVEMENT OF THE SURGICAL MARGINS BY EITHER INVASIVE OR IN SITU. CARCINOMA IS IDENTIFIED. - NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - THE ATTACHED SKELETAL MUSCLE IS UNINVOLVED BY CARCINOMA. THE NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE CHANGES AND. PROLIFERATIVE FIBROCYSTIC CHANGES. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF POSITIVE. LYMPH NODES IN RELATION TO THE TOTAL NUMBER OF LYMPH NODES EXAMINED) : LEVEL. I: 1/10. - THERE IS EXTRANODAL EXTENSION OF CARCINOMA, >2 MM. IMMUNOHISTOCHEMICAL STAINS WERE PERFORMED ON FORMALIN-FIXED TISSUE WITH. THE FOLLOWING RESULTS FOR INVASIVE CARCINOMA (BLOCK 5T5) : ESTROGEN RECEPTOR (6F11,. 90% NUCLEAR STAINING WITH. STRONG INTENSITY. PROGESTERONE RECEPTOR (1E2;. 608 NUCLEAR STAINING WITH. MODERATE INTENSITY. NEGATIVE (STAINING. HER2 (HERCEPTEST; DAKO) : INTENSITY OF 0). CONTROLS ARE SATISFACTORY. COMMENT: HERCEPTESTTM (DAKO) IS AN FDA-APPROVED METHOD FOR. ASSESSMENT OF HER2 PROTEIN OVEREXPRESSION IN BREAST CANCER TISSUE ROUTINELY. PROCESSED FOR HISTOLOGICAL EVALUATION. THE HER2 TEST RESULTS ARE REPORTED IN. ACCORDANCE WITH THE ASCO/CAP GUIDELINE RECOMMENDATIONS FOR HER2 TESTING IN. BREAST CANCER (J CLIN ONCOL 2007; 25 (1) :1-28) . I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. ER-C. PR-C. HER2-C. IMM RECUT. NEG CONT. NEG-HER2. Gross Description: MD. D. 1.) The specimen is received in formalin, labeled "level 3 left axillary. lymph nodes" and consists of two irregularly shaped fragments of yellow. lobulated adipose tissue measuring 1.0 x 1.0 x 0.2 cm in aggregate. No. lymph nodes are identified grossly. The specimen is entirely submitted. Summary of sections: U-undesignated. 2.) The specimen is received in formalin, labeled "level 2 left axillary. lymph nodes" and consists of one irregularly shaped fragment of yellow. lobulated adipose tissue measuring 3.5 x 2.5 x 0.3 cm. Three possible lymph. nodes are identified, ranging from 0.3 cm to 0.5 cm in greatest dimension. The lymph nodes are entirely submitted. Summary of sections: U undesignated. I.D. 3.) The specimen is received in formalin, labeled "lateral left breast. skin" and consists of one irregularly shaped fragment of yellow to tan. fibroadipose tissue measuring 10.3 x 2.9 x 1.4 cm. No skin is identified. grossly. Serial sectioning reveals a grossly unremarkable fibroadipose. tissue with a single possible lymph node measuring 0.4 cm in greatest. dimension. Representative sections are submitted. Summary of sections: U-undesignated. .D. 4.) The specimen is received in formalin, labeled "right upper abdominal. skin tag" and consists of one polypoid shaped fragment of brown skin. measuring 0.3 x 0.2 x 0.2 cm. The specimen is entirely submitted. Summary of sections: U-undesignated. ..D. 5.) The specimen is received fresh, labeled "left breast and level 1. axillary lymph nodes, stitch marks level 1 axillary lymph nodes" and. consists of a breast with attached axillary tail. The breast measures. 22.2. x 16.0 x 3.5 cm with overlying skin ellipse measuring 16.6 x 7.9 cm. Situated eccentrically on the skin surface is an everted nipple measuring. 1.2 x 1.1 x 0.3 cm and areola measuring 4.9 x 4.1 cm. The skin shows no. scars. A suture demarcates the axillary tail which measures 9.8 x 5.5 x 1.5. cm. The posterior surface of the breast is inked black and the specimen is. serially sectioned to reveal an irregularly shaped white-tan firm mass. measuring 11.0 x 6.5 x 4.8 cm, involving upper outer, lower outer and upper. inner quadrants, located 0.6 cm away from the deep resection margin. The. remaining breast tissue shows predominantly yellow lobulated adipose tissue. admixed with scant white-tan fibrous soft tissue with no other grossly. identifiable lesions. The axillary tissue is dissected to reveal multiple. lymph nodes ranging in size from 0.5 cm to 2.5 cm. The specimen is. submitted for lymph node dissection. Representative sections of the. mastectomy specimen and all identified axillary lymph nodes are submitted. Tissue submitted for TPS. Summary of sections: N - nipple. NB - nipple base. S skin. D - deep margin. T - tumor. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. LNS -- lymph nodes. Summary of Sections: Part 1: SP: Level three left axillary lymph nodes. Block. Sect. Site. PCs. 1. U. 1. Part 2: SP: Level two left axillary lymph nodes. Block. Sect. Site. PCs. 1. U. 1. Part 3: SP: Lateral left breast skin (sr). Block. Sect. Site. PCs. 1. U. 1. Part 4: SP: Right upper abdominal skin tag. Block. Sect. Site. PCs. 1. U. 1. Part 5: SP: Left breast and level 1 axillary lymph nodes. Block. Sect. Site. PCs. 1. D. 1. 2. LIQ. 2. 6. LN. 11. 2. LOQ. 2. 1. N. 1. 1. NB. 1. S. 1. 5. T. 5. 2. UIQ. 2. 2. UOQ. 2.

expanded version (tokens=2511) : 
 The breast pathology report describes a case of invasive ductal carcinoma with ductal carcinoma in situ (DCIS) identified in the left breast with some involvement of nearby lymph nodes. The report indicates:

- Histological classification: Invasive ductal carcinoma with DCIS
- Subtype: Not specified
- Description of necrosis: Extensive necrosis is present in the DCIS
- Tumor infiltrating lymphocytes: No mention
- Histological grade: Histologic grade III/III (slight or no tubule formation)
- Nuclear grade: Nuclear grade II/III (moderate variation in size and shape)
- Lymphovascular invasion: Extensive vascular invasion is present
- Calcification: Calcifications are present in the in situ and invasive carcinoma
- Receptor status: Estrogen receptor positive (90% nuclear staining with strong intensity), progesterone receptor positive (60-80% nuclear staining with moderate intensity), HER2 negative
- IHC and ancillary testing results: HER2-C is negative

Additionally, the report describes the presence of benign fibroadipose tissue in multiple specimens submitted from different parts of the breast and lymph nodes. The lymph node status is also reported, indicating lymph node involvement in level I (1/10 nodes involved) with extranodal extension of the carcinoma greater than 2mm.

It's important to note that histological classification, subtype, histological grade, nuclear grade, receptor status, and other testing results are

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2681) : 
 Report reveals the presence of invasive ductal carcinoma with DCIS in the left breast with some involvement of nearby lymph nodes. Histologic grade is III/III with moderate variation in nuclear size and shape. Estrogen and progesterone receptors are positive, while HER2 is negative. Necrosis is present within DCIS, but no tumor-infiltrating lymphocytes are detectable. Extensive vascular invasion and calcifications are observed. Level I axillary lymph node involvement with extranodal extension is identified. Benign fibroadipose tissue is also detected in multiple specimens submitted from various parts of the breast.

